Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 2
1954 1
1955 1
1957 1
1963 5
1964 6
1966 1
1967 2
1969 4
1970 4
1971 3
1972 5
1974 1
1975 1
1976 4
1977 6
1978 3
1979 4
1980 2
1981 1
1982 7
1983 6
1984 11
1985 14
1986 5
1987 23
1988 23
1989 12
1990 21
1991 9
1992 31
1993 29
1994 28
1995 21
1996 26
1997 23
1998 28
1999 15
2000 24
2001 27
2002 23
2003 37
2004 33
2005 22
2006 34
2007 35
2008 46
2009 45
2010 34
2011 49
2012 49
2013 56
2014 66
2015 81
2016 103
2017 118
2018 128
2019 139
2020 180
2021 195
2022 219
2023 227
2024 229
2025 301
2026 249

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,787 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Liberman-Pincu
Page 1
ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis.
Zheng F, Geng Z, Ye C, Hao M, Sha M, Shan H, Zhou Y, Jiang A, Hou W, Chen A, Susan BD, Wang J, Li Q, Xiong X. Zheng F, et al. Arterioscler Thromb Vasc Biol. 2026 May;46(5):e324169. doi: 10.1161/ATVBAHA.125.324169. Epub 2026 Mar 5. Arterioscler Thromb Vasc Biol. 2026. PMID: 41783930 Free article.
ELA or saline was infused via osmotic minipumps into mice for 4 weeks. Transcriptomic studies and VSMC-derived conditioned medium were used to investigate the downstream molecular mechanisms of ELA. ...ELA shows promise as a target for pharmacological therapy …
ELA or saline was infused via osmotic minipumps into mice for 4 weeks. Transcriptomic studies and VSMC-derived conditioned medium wer …
mPEG@ELA-11 Alleviates Atherosclerosis via AKT-ER Stress-Mediated Macrophage Modulation.
Li X, Dou N, Zhong L, Wu Y, Cai Z, Zhao Z, Qu L, Jiang Q. Li X, et al. BME Front. 2025 Nov 25;6:0203. doi: 10.34133/bmef.0203. eCollection 2025. BME Front. 2025. PMID: 41306397 Free PMC article.
Objective: This study explores the role of methoxy polyethylene glycol@Elabela-11 (mPEG@ELA-11), a pH-responsive ELA-11 conjugate, in modulating macrophage function and attenuating atherosclerosis, focusing on the protein kinase B (AKT)-mediated endoplasmic reticulu …
Objective: This study explores the role of methoxy polyethylene glycol@Elabela-11 (mPEG@ELA-11), a pH-responsive ELA-11 conjug …
Early life adversity and adult attention-deficit/hyperactivity disorder (ADHD): Pathways to persistence and adult susceptibility.
Zou P, Huang Z, Zong X, Zhang Q. Zou P, et al. Neurosci Biobehav Rev. 2025 Dec;179:106436. doi: 10.1016/j.neubiorev.2025.106436. Epub 2025 Oct 23. Neurosci Biobehav Rev. 2025. PMID: 41138932 Free PMC article. Review.
Drawing on extensive human clinical research and advancements in ELA animal models, this review critically examines the evidence linking ELA and adult ADHD. The findings indicate that ELA significantly contributes to the persistence of ADHD and increases vuln …
Drawing on extensive human clinical research and advancements in ELA animal models, this review critically examines the evidence link …
Roles of an endogenous peptide ELABELA in ameliorating hyperuricemia by inhibiting uric acid production via CYP27A1-modulated bile acid metabolism in mice.
Leng Y, Xie T, Tao Y, Zeng Y, Zhu Q, Wang L. Leng Y, et al. Biochem Pharmacol. 2025 Dec;242(Pt 4):117408. doi: 10.1016/j.bcp.2025.117408. Epub 2025 Oct 9. Biochem Pharmacol. 2025. PMID: 41067286
ELABELA (ELA), an endogenous peptide, exhibits antioxidant and anti-inflammatory properties in the heart and kidney. ...Compared with the HUA group, both ELA peptides significantly reduced serum UA levels, as well as hepatic expression and activity of XOD. ...
ELABELA (ELA), an endogenous peptide, exhibits antioxidant and anti-inflammatory properties in the heart and kidney. ...Compared with …
Addressing the biological embedding of early life adversities (ELA) among adults through mindfulness: Proposed mechanisms and review of converging evidence.
Sun S, Sheridan MA, Tyrka AR, Donofry SD, Erickson KI, Loucks EB. Sun S, et al. Neurosci Biobehav Rev. 2022 Mar;134:104526. doi: 10.1016/j.neubiorev.2022.104526. Epub 2022 Jan 5. Neurosci Biobehav Rev. 2022. PMID: 34998833 Free PMC article. Review.
This paper presents evidence for mindfulness training to reduce the elevated mental and physical health risks linked to ELA among adults by targeting biological mechanisms of ELA leading to these adverse health outcomes. ...If effective, a mindfulness-based approach …
This paper presents evidence for mindfulness training to reduce the elevated mental and physical health risks linked to ELA among adu …
Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy.
Ye C, Xu T, Yang H, Zheng F, Zhang K, Xin W, Tang X, Li Y, Hang J, Li G, Xu H, Shen S, Yang M, Li P, Xiong X, Sun N. Ye C, et al. J Adv Res. 2026 Jun 21:S2090-1232(26)00509-6. doi: 10.1016/j.jare.2026.06.027. Online ahead of print. J Adv Res. 2026. PMID: 42324018 Free article.
OBJECTIVES: This study aimed to determine the role of ELA in hereditary HCM and to assess the therapeutic potential of restoring ELA signaling. ...The effects of ELA were evaluated using AAV9-mediated overexpression and chronic administration of mature ELA …
OBJECTIVES: This study aimed to determine the role of ELA in hereditary HCM and to assess the therapeutic potential of restoring E …
Early life adversities, psychopathologies and novel pharmacological strategies.
Cattaneo A, Begni V, Zonca V, Riva MA. Cattaneo A, et al. Pharmacol Ther. 2024 Aug;260:108686. doi: 10.1016/j.pharmthera.2024.108686. Epub 2024 Jul 3. Pharmacol Ther. 2024. PMID: 38969307 Free article. Review.
Exposure to adversities during early life stages (early life adversities - ELA), ranging from pregnancy to adolescence, represents a major risk factor for the vulnerability to mental disorders. Hence, it is important to understand the molecular and functional underpinning …
Exposure to adversities during early life stages (early life adversities - ELA), ranging from pregnancy to adolescence, represents a …
Early life adversity impaired dorsal striatal synaptic transmission and behavioral adaptability to appropriate action selection in a sex-dependent manner.
de Carvalho G, Khoja S, Haile MT, Chen LY. de Carvalho G, et al. Front Synaptic Neurosci. 2023 Apr 5;15:1128640. doi: 10.3389/fnsyn.2023.1128640. eCollection 2023. Front Synaptic Neurosci. 2023. PMID: 37091877 Free PMC article.
At the circuit level, ELA decreased corticostriatal glutamate transmission in male but not in female mice. Interestingly, in DMS, glutamate transmission is decreased in male ELA mice, but increased in female ELA mice. ELA impaired the ability to update …
At the circuit level, ELA decreased corticostriatal glutamate transmission in male but not in female mice. Interestingly, in DMS, glu …
Pharmacological Inhibition of FKBP51 Mitigates Early Life Adversity-Induced Social Deficits in Male Mice.
Bordes J, Ji X, Gasperoni S, Sudre-Chinsky C, Kalbasi A, Harbich D, Flachskamm C, Fontanet P, Narayan S, Uhr M, Namendorf C, Bellone C, Chen A, Hausch F, Lopez JP, Schmidt MV. Bordes J, et al. Adv Sci (Weinh). 2026 Aug;13(48):e76040. doi: 10.1002/advs.76040. Epub 2026 Jun 9. Adv Sci (Weinh). 2026. PMID: 42263247 Free PMC article.
We tested if pharmacological inhibition of FKBP51 with the selective inhibitor SAFit2 prevents the long-term consequences of ELA. Male mice exposed to ELA exhibited persistent deficits in social behavior, manifesting as social subordination in adolescence and adulth …
We tested if pharmacological inhibition of FKBP51 with the selective inhibitor SAFit2 prevents the long-term consequences of ELA. Mal …
Early-Life Adversity and Epigenetic Aging: Findings from a 17-Year Longitudinal Study.
Barr E, Comtois-Cabana M, Coope A, Coté SM, Kobor MS, Konwar C, Lupien S, Geoffroy MC, Boivin M, Provençal N, Catherine NLA, Dennis JK, Ouellet-Morin I. Barr E, et al. Biomolecules. 2025 Jun 18;15(6):887. doi: 10.3390/biom15060887. Biomolecules. 2025. PMID: 40563527 Free PMC article.
Youth exposed to early-life adversity (ELA) are at greater risk for poorer physical and mental health outcomes in adolescence and adulthood. ...The findings suggest that DunedinPACE may be more sensitive to variations in ELA than other clocks. Future research should …
Youth exposed to early-life adversity (ELA) are at greater risk for poorer physical and mental health outcomes in adolescence and adu …
2,787 results